Asia Deal Watch: Otsuka Lands Second Alliance With Ionis, Focused On ALS Subpopulation

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Plus deals involving Zai Lab/Pfizer, Laekna/Lilly, Takeda/Alloy, Lunit/AstraZeneca, VelaVigo/Avenzo, Biosion/Aclaris, HCW/WY Biotech, Celltrion/iQone and Kaken/Numab.

Asia Deal Watch
• Source: Alamy

More from Companies

More from Focus On Asia